Is 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-? Is 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- safe for nursing mother and child? Does 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- extracts into breast milk? Does 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- has any long term or short term side effects on infants? Can 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- influence milk supply or can 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- decrease milk supply in lactating mothers?
Answer by DrLact: About 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- usage in lactation
No information is available on the clinical use of 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)- therapy and for 2 weeks following therapy.
Alternate Drugs
Gemcitabine(Dangerous)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Letrozole(Dangerous)
Bevacizumab(Low Risk)
Dactinomycin(Dangerous)
Tamoxifen(Dangerous)
Exemestane(Dangerous)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Etoposide(Dangerous)
Pazopanib(Unsafe)
Doxorubicin(Dangerous)
Ipilimumab(Unsafe)
Cyclophosphamide(Dangerous)
Imatinib(Unsafe)
Cetuximab(Unsafe)
Cisplatin(Unsafe)
Nivolumab(Unsafe)
Carboplatin(Dangerous)
Busulfan(Dangerous)
Vinblastine(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Allopurinol(Safe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)